Regulation of estrogen receptor activation of the prolactin enhancer/promoter by antagonistic activation function-2-interacting proteins

Molecular Endocrinology

Volumn 13, Issue 6, 1999, Pages 935-945

  Schaufele, F ^a  

^a UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ESTROGEN; ESTROGEN RECEPTOR; PROLACTIN; TRANSCRIPTION FACTOR;

ARTICLE; BINDING AFFINITY; DNA SEQUENCE; ENHANCER REGION; GENE EXPRESSION; HORMONAL REGULATION; PRIORITY JOURNAL; PROLACTIN RELEASE; PROMOTER REGION; PROTEIN EXPRESSION; RECEPTOR BINDING; STEM CELL; WESTERN BLOTTING;

EID: 0033304629     PISSN: 08888809     EISSN: None     Source Type: Journal    
DOI: 10.1210/mend.13.6.0298     Document Type: Article

References (64)

1. Role of co-activators and co-repressors in the mechanism of steroid/thyroid receptor action
2. The nuclear hormone receptor gene superfamily
3. Transcriptional activation by oestrogen receptors
4. Tripartite steroid hormone receptor pharmacology: Interaction with multiple effector sites as a basis for the cell- and promoter-specific action of these hormones
5. Nuclear receptor coactivators and corepressors
6. Nuclear receptor coactivators
7. The yeast Ada complex mediates the ligand-dependent activation function AF-2 of retinoid X and estrogen receptors
8. Differential ligand-dependent interactions between the AF-2 activating domain of nuclear receptors and the putative transcriptional intermediary factors mSUG1 and TIF1
9. The transcriptional coactivator p/CIP binds CBP and mediates nuclear-receptor function
10. Sequence and characterization of a coactivator for the steroid hormone receptor superfamily
11. Two classes of proteins dependent on either the presence or absence of thyroid hormone for interaction with the thyroid hormone receptor
12. Interaction of thyroid-hormone receptor with a conserved transcriptional mediator
13. The N-terminal part of TIF1, a putative mediator of the ligand-dependent activation function (AF-2) of nuclear receptors, is fused to B-raf in the oncogenic protein T18
14. Two distinct nuclear receptor interaction domains in NSD1, a novel SET protein that exhibits characteristics of both corepressors and coactivators
15. GRIP1, A novel mouse protein that serves as a transcriptional coactivator in yeast for the hormone binding domains of steroid receptors
16. GRIP1, A transcriptional coactivator for the AF-2 transactivation domain of steroid, thyroid, retinoid, and vitamin D receptors
17. Nuclear receptor coactivator ACTR is a novel histone acetyltransferase and forms a multimeric activation complex with P/CAF and CBP/p300
18. Nuclear factor RIP140 modulates transcriptional activation by the estrogen receptor
19. Ligand-dependent interaction between the estrogen receptor and the human homologues of SWI2/SNF2
20. Identification of a conserved region required for hormone dependent transcriptional activation by steroid hormone receptors
21. Human estrogen receptor transactivational capacity is determined by both cellular and promoter context and mediated by two functionally distinct intramolecular regions
22. Ligand-dependent, transcriptionally productive association of the amino- and carboxyl-terminal regions of a steroid hormone nuclear receptor
23. Identification of TRACs (T3 receptor-associating cofactors), a family of cofactors that associate with, and modulate the activity of, nuclear hormone receptors
24. A nuclear hormone receptor corepressor mediates transcriptional silencing by receptors with distinct repression domains
25. Two receptor interacting domains in the nuclear hormone receptor corepressor RIP13/N-CoR
26. Nuclear receptor repression mediated by a complex containing SMRT, mSin3A, and histone deacetylase
27. The histone acetylase PCAF is a nuclear receptor coactivator
28. Analysis of estrogen receptor transcriptional enhancement by a nuclear hormone receptor coactivator
29. Enhancement of estrogen receptor transcriptional activity by the coactivator GRIP-1 highlights the role of activation function 2 in determining estrogen receptor pharmacology
30. Functional interactions of the AF-2 activation domain core region of the human androgen receptor with the amino-terminal domain and with the transcriptional coactivator TIF2 (transcriptional intermediary factor 2)
31. Both Pit-1 and the estrogen receptor are required for estrogen responsiveness of the rat prolactin gene
32. Pituitary cell phenotypes involve cell-specific Pit-1 mRNA translation and synergistic interactions with other classes of transcription factors
33. Pit-1 binding to specific DNA sites as a monomer or dimer determines gene-specific use of a tyrosine-dependent synergy domain
34. An activation function in Pit-1 required selectively for synergistic transcription
35. Activities in Pit-1 determine whether receptor interacting protein 140 activates or inhibits Pit-1/nuclear receptor transcriptional synergy
36. GHF-1-promoter-targeted immortalization of a somatotropic progenitor cell results in dwarfism in transgenic mice
37. Dwarf locus mutants lacking three pituitary cell types result from mutations in the POU-domain gene pit-1
38. Nuclear protein CBP is a coactivator for the transcription factor CREB
39. A CBP integrator complex mediates transcriptional activation and AP-1 inhibition by nuclear receptors
40. Clustered point mutation analysis of the rat prolactin promoter
41. Structure-function analysis of the rat prolactin promoter: Phasing requirements of proximal cell-specific elements
42. P-Lim, a LIM homeodomain factor, is expressed during pituitary organ and cell commitment and synergizes with Pit-1
43. Interaction of Ets-1 and the POU-homeodomain protein GHF-1/Pit-1 reconstitutes pituitary-specific gene expression
44. The c-Jun delta-domain inhibits neuroendocrine promoter activity in a DNA sequence- and pituitary-specific manner
45. CCAAT/enhancer-binding protein alpha activation of the rat growth hormone promoter in pituitary progenitor GHFT1-5 cells
46. P-OTX: A PIT-1-interacting homeodomain factor expressed during anterior pituitary gland development
47. Tamoxifen activation of the estrogen receptor/AP-1 pathway: Potential origin for the cell-specific estrogen-like effects of antiestrogens
48. Differential ligand activation of estrogen receptors ERα and ERβ at AP1 sites
49. Molecular basis of agonism and antagonism in the oestrogen receptor
50. Cloning of a novel receptor expressed in rat prostate and ovary
51. Comparison of the ligand binding specificity and transcript tissue distribution of estrogen receptors α and β
52. Role of estrogen receptor-alpha in the anterior pituitary gland
53. Transcription factor AP1 is involved in basal and okadaic acid-stimulated activity of the human PRL promoter
54. Differential interaction of nuclear receptors with the putative human transcriptional coactivator hTIF1
55. Mechanistic aspects of estrogen receptor activation probed with constitutively active estrogen receptors: Correlations with DNA and coregulator interactions and receptor conformational changes
56. AF-2 activity and recruitment of steroid receptor coactivator 1 to the estrogen receptor depend on a lysine residue conserved in nuclear receptors
57. Nuclear receptor-binding sites of coactivators glucocorticoid receptor interacting protein 1 (GRIP1) and steroid receptor coactivator 1 (SRC-1): Multiple motifs with different binding specificities
58. A regulatory role for RIP140 in nuclear receptor activation
59. A signature motif in transcriptional co-activators mediates binding to nuclear receptors
60. The molecular biology of thyroid hormone action
61. Synergistic activation of the rat growth hormone promoter by Pit-1 and the thyroid hormone receptor
62. Hormone-dependent coactivator binding to a hydrophobic cleft on nuclear receptors
63. Discrete cis-active genomic sequences dictate the pituitary cell type-specific expression of rat prolactin and growth hormone genes
64. Functional domains of the human estrogen receptor